Atom-based enumeration: New eribulin analogues with low susceptibility to P-glycoprotein-mediated drug efflux

Atom-based enumeration: New eribulin analogues with low susceptibility to P-glycoprotein-mediated drug efflux Novel second generation analogs of eribulin. Part II: Orally available and active against resistant tumors in vivo Novel second generation analogs of eribulin. Part I: Compounds containing a lipophilic C32 side chain overcome P-glycoprotein susceptibility Novel second generation analogs of eribulin. Part III: Blood–brain barrier permeability and in vivo activity in a brain tumor model Effects of Isoprenoid Analogues ofSDB-Ethylenediamine on Multidrug Resistant Tumor Cells Alone and in Combination with Chemotherapeutic Drugs Optimization by Molecular Fine Tuning of Dihydro-β-agarofuran Sesquiterpenoids as Reversers of P-Glycoprotein-Mediated Multidrug Resistance De Novo Prediction of P-Glycoprotein-Mediated Efflux Liability for Druglike Compounds C-7 Analogues of Progesterone as Potent Inhibitors of the P-Glycoprotein Efflux Pump Ecdysteroid Derivatives that Reverse P-Glycoprotein-Mediated Drug Resistance Comprehensive Synthesis of Amino Acid-Derived Thiazole Peptidomimetic Analogues to Understand the Enigmatic Drug/Substrate-Binding Site of P-Glycoprotein